yahoo_financeOriginal article
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
Data ReadoutpositiveEMPAVELIPositive
AI Analysis
Summary
Biogen's EMPAVELI Phase 3 pediatric study data published in Clinical Journal of the American Society of Nephrology demonstrated reduction in proteinuria and stabilized kidney function in adolescents with C3G or primary IC-MPGN.
Clinical Trial Data
Phase
Phase 3
Primary Endpoint
Met
Outcome Details
Phase 3 pediatric data showed reduction in proteinuria and stabilized kidney function in adolescents with C3G or primary IC-MPGN
Importance:7/10
Sentiment:
0.70
Phase 3pediatrickidney diseaseC3GIC-MPGNclinical data publication
Related Companies
Read the original article
Published by yahoo_finance on September 17, 2026 8:15 PM